FDA OKs Shire drug for binge-eating use The U.S. Food and Drug Administration yesterday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition. Shire's U.S. headquarters is based...
22.26 | 0
komentar | Read More